TY - JOUR
T1 - Life course trajectories of cardiovascular risk
T2 - Impact on atherosclerotic and metabolic indicators
AU - Pollock, Benjamin D.
AU - Stuchlik, Patrick
AU - Harville, Emily W.
AU - Mills, Katherine T.
AU - Tang, Wan
AU - Chen, Wei
AU - Bazzano, Lydia A.
N1 - Funding Information:
This work was supported by R01 ES021724 from the National Institute of Environmental Health Sciences and R01 AG041200 from the National Institute on Aging . This research was also funded in part by The Prize Paper Award from the Michigan State University Department of Epidemiology and Biostatistics.
Funding Information:
This work was supported by R01 ES021724 from the National Institute of Environmental Health Sciences and R01 AG041200 from the National Institute on Aging. This research was also funded in part by The Prize Paper Award from the Michigan State University Department of Epidemiology and Biostatistics.
Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2019/1
Y1 - 2019/1
N2 - Background and aims: In this analysis, we estimated population-level trajectory groups of life course cardiovascular risk to explore their impact on mid-life atherosclerotic and metabolic outcomes. Methods: This prospective study followed n = 1269 Bogalusa Heart participants, each with at least 4 study visits from childhood in 1973 through adulthood in 2016. We used discrete mixture modeling to determine trajectories of cardiovascular risk percentiles from childhood to adulthood. Outcomes included mid-life subclinical atherosclerotic measures [(carotid intima-media thickness (cIMT), pulse wave velocity (PWV)], metabolic indicators [(diabetes and body mass index (BMI)], and short physical performance battery (SPPB). Results: Between the mean ages of 9.6–48.3 years, we estimated five distinct trajectory groups of life course cardiovascular risk (High-Low, High-High, Mid-Low, Low-Low, and Low-High). Adult metabolic and vascular outcomes were significantly determined by life course cardiovascular risk trajectory groups (all p < 0.01). Those in the High-Low group had lower risks of diabetes (20% vs. 28%, respectively; p =.12) and lower BMIs (32.4 kg/m2 vs. 34.6 kg/m2; p =.06) than those who remained at high risk (High-High) throughout life. However, the High-Low group had better cIMT (0.89 mm vs. 1.05 mm; p <.0001) and PWV (7.8 m/s vs. 8.2 m/s; p =.03) than the High-High group. For all outcomes, those in the Low-Low group fared best. Conclusions: We found considerable movement between low- and high-relative cardiovascular risk strata over the life course. Children who improved their relative cardiovascular risk over the life course achieved better mid-life atherosclerotic health despite maintaining relatively poor metabolic health through adulthood.
AB - Background and aims: In this analysis, we estimated population-level trajectory groups of life course cardiovascular risk to explore their impact on mid-life atherosclerotic and metabolic outcomes. Methods: This prospective study followed n = 1269 Bogalusa Heart participants, each with at least 4 study visits from childhood in 1973 through adulthood in 2016. We used discrete mixture modeling to determine trajectories of cardiovascular risk percentiles from childhood to adulthood. Outcomes included mid-life subclinical atherosclerotic measures [(carotid intima-media thickness (cIMT), pulse wave velocity (PWV)], metabolic indicators [(diabetes and body mass index (BMI)], and short physical performance battery (SPPB). Results: Between the mean ages of 9.6–48.3 years, we estimated five distinct trajectory groups of life course cardiovascular risk (High-Low, High-High, Mid-Low, Low-Low, and Low-High). Adult metabolic and vascular outcomes were significantly determined by life course cardiovascular risk trajectory groups (all p < 0.01). Those in the High-Low group had lower risks of diabetes (20% vs. 28%, respectively; p =.12) and lower BMIs (32.4 kg/m2 vs. 34.6 kg/m2; p =.06) than those who remained at high risk (High-High) throughout life. However, the High-Low group had better cIMT (0.89 mm vs. 1.05 mm; p <.0001) and PWV (7.8 m/s vs. 8.2 m/s; p =.03) than the High-High group. For all outcomes, those in the Low-Low group fared best. Conclusions: We found considerable movement between low- and high-relative cardiovascular risk strata over the life course. Children who improved their relative cardiovascular risk over the life course achieved better mid-life atherosclerotic health despite maintaining relatively poor metabolic health through adulthood.
KW - Atherosclerosis
KW - Epidemiological methods
KW - Life course cardiovascular risk
KW - Metabolic disease
KW - Trajectory analysis
UR - http://www.scopus.com/inward/record.url?scp=85056620425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056620425&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2018.11.008
DO - 10.1016/j.atherosclerosis.2018.11.008
M3 - Article
C2 - 30453117
AN - SCOPUS:85056620425
SN - 0021-9150
VL - 280
SP - 21
EP - 27
JO - Atherosclerosis
JF - Atherosclerosis
ER -